Announcement • Mar 29
Electriq Power Holdings, Inc. announced delayed annual 10-K filing On 03/28/2024, Electriq Power Holdings, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC. Announcement • Jan 18
NYSE Regulation Determines to Commence Proceedings to Delist the Electriq Power Holdings' Class A Common Stock from NYSE On January 16, 2024, Electriq Power Holdings, Inc. (the “Company”) received written notice from the staff of NYSE Regulation (“NYSE Regulation”) that it has determined to commence proceedings to delist the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”), from the New York Stock Exchange (the “NYSE”) and that trading in the Common Stock was suspended immediately. NYSE Regulation reached its determination that the Common Stock is no longer suitable for listing because the Company had fallen below the NYSE’s continued listing standard that requires listed companies to maintain an average global market capitalization over a consecutive 30 trading day period of at least $15,000,000, pursuant to Section 802.01B of the NYSE Listed Company Manual. NYSE Regulation indicated that it will apply to the U.S. Securities and Exchange Commission (the “SEC”) to delist the Common Stock upon completion of all applicable procedures, which provide, among other things, that the Company has the right to appeal NYSE Regulation’s decision within 10 business days following receipt of notice thereof. The Company expects to appeal NYSE Regulation’s determination to delist the Common Stock. If the Company later determines to withdraw its appeal or the appeal is unsuccessful, it is expected that the Common Stock would be delisted from the NYSE at such time. The Company anticipates that its Common Stock will begin trading in the over-the-counter market under its current symbol (ELIQ) when the Common Stock is suspended from trading on the NYSE. The over-the-counter market is a significantly more limited market than the NYSE, and quotation on the over-the-counter market likely results in a less liquid market for existing and potential stockholders of the Company to trade the Common Stock and could further depress the trading price of the Common Stock. The Company can provide no assurance that its Common Stock will continue to trade on this market, that broker-dealers will continue to provide public quotes of the Common Stock on this market, or that the trading volume of the Common Stock will be sufficient to provide for an efficient trading market. The transition of the Common Stock to the over-the-counter market will not affect the Company’s business operations or its reporting requirements under the rules of the SEC. Reported Earnings • Jan 15
Third quarter 2023 earnings released: US$0.74 loss per share (vs US$6.65 loss in 3Q 2022) Third quarter 2023 results: US$0.74 loss per share. Net loss: US$20.0m (loss widened 88% from 3Q 2022). 
